ÃâÒßѧÊÔÌâ
]:(>
r&' Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£©
T
OdH 1. Fas(CD95)/FasL
nu
d,ag 2. common chain of cytokine receptor
>d!w&0z> 3 . TCR/CD3 complex
}jBr[S5 4. negaive selection of thymocytes
;2q;RT`h 5. artificial active immune
fQi7e5 6. anti-idiotypic
QDYS}{A:V 7. IgSF
-l8n0P1+ 8. Integrin
M7^PWC 9. chemokine
oe_l:Y% 10. B7/CD28
1dh_"/ ¶þ. ÎÊ´ðÌ⣨ÿÌâ12·Ö£¬¹²60·Ö£©
+8Yt91 1. ±È½ÏMHC¢ñºÍMHC¢òÀ࿹ԲÎÓëµÄ¼Ó¹¤Ìá³Ê¿¹ÔµÄ¹ý³Ì¡£
-B
fZ P5 2. ±È½ÏCTLºÍNKɱÉ˰Ðϸ°ûʱʶ±ðºÍɱÉË»úÖÆµÄÌØµã¡£
d!7cIYVZ 3. ±È½ÏÃâÒßѧ¼ì²â·¨ºÍÉúÎïѧ»îÐÔ¼ì²â·¨¼ì²âϸ°ûÒò×ÓµÄÓÅȱµã¡£ 4. ·¢ÏÖÒ»ÖÖеİ×ϸ°û·Ö»¯¿¹Ô»òÖ×ÁöÏà¹Ø¿¹Ô,²¢ÖƱ¸Á˵¥¿Ë¡¿¹Ìå,ÊÔÉè¼ÆÊµÑé·½°¸¿Ë¡´Ë»ùÒò¡£
,LKY?=T$z 5. Ñ¡ÔñÏÂÊöÖÐÒ»¸öרÌâ,ÐðÊöÎÒ¹úÔÚÕâÒ»Ñо¿ÁìÓòµÄÏÖ×´¼°ÃæÁÙµÄÌôÕ½
z=<x.F
m663%b(5> 1)Ö×ÁöÃâÒߣ»(2)»ùÒòÖÎÁÆ£»(3)CD¿¹Ô¡£
hAi50q;z µÚËľüÒ½´óѧһ¾Å¾ÅÆßÄ격ʿÑо¿ÉúÈëѧ¿¼ÊÔÃâÒßѧÊÔÌâ
AX}l~
sv Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£©
n
F0$ 1. B7/CD28
RKFj6u 2. Th1 subset
^$f}s,09 3. seven predicated transmembrane domain receptor superfamily£¨STR superfamily£©
2LGeRw 4. antibody affinity maturation
g#ubxC7t< 5. AP-1
*2N$l>ql:k 6. single chain variable fragment£¨ScFv£©
" NnUu8x 7. NK cell receptor
mG@xehH 8. Zinkernagel-Doherty phenomenon
"gjy+eosY 9. Ig fold
5jD2%"YUV 10. CD40/CD40L
%$|=_K)Ks ¶þ. ÎÊ´ðÌ⣨ÿÌâ12·Ö£¬¹²36·Ö£©
5BR
9f3} 1. ÊÔÊöÐØÏÙ΢»·¾³¶ÔÐØÏÙϸ°ûµÄÑ¡Ôñ×÷Óü°ÆäÓëTϸ°û¹¦ÄÜÐÔÑÇȺÐγɵĹØÏµ¡£
|_/q0#" 2. ÊÔÊöÌåÒºÃâÒßÓ¦´ðµÄ¹æÂÉ£¬»ØÒä·´Ó¦ºÍ¿¹ÌåÀà±ðת»»µÄ»úÖÆÊÇʲô£¿
Q4\EI=4P] 3. ÊԴӽṹºÍ¹¦ÄܵȽǶȣ¬²ûÊö°×ϸ°û·Ö»¯¿¹Ô£¨CD£©¡¢Õ³¸½·Ö×Ó£¨integrin£©ºÍÃâÒßÇòµ°°×³¬¼Ò×壨IgSF£©ÈýÀà·Ö×ÓµÄÏ໥¹ØÏµ¡£Ä¿Ç°ÔÚÕâÒ»ÁìÓòÖÐÖ÷ÒªÑо¿ÈȵãÊÇʲô£¿
"f/lm 2< Èý. ÎÊ´ðÌ⣨24·Ö£¬µÚ1ÌâΪÃâÒßѧרҵ¿¼ÉúÊÔÌ⣬µÚ2ÌâΪѪҺ²¡Ñ§¿Æ¿¼ÉúÊÔÌ⣬µÚ3ÌâΪÏû»¯ÄÚ¿Æ¿¼ÉúÊÔÌ⣬ֻÔÊÐí´ð±¾×¨ÒµÊÔÌ⣩
uoR_/vol8 1. ÊԱȽÏTCRºÍBCR½á¹¹¼°Æäʶ±ð¿¹Ô¡¢ÁܰÍϸ°û»î»¯ÐźŵķÖ×Ó»úÀí¡££¨ÃâÒßѧרҵ£©¡£
s9svuFb 2. ÊÔÊö°×Ѫ²¡ÃâÒßѧ·ÖÐÍÀíÂۺͷ½·¨µÄÑо¿½øÕ¹¡££¨ÑªÒº²¡Ñ§×¨Òµ£©¡£
Cp=DdmR 3. ÊÔÊöÖ×ÁöÒßÃçµÄÑо¿½øÕ¹¡££¨Ïû»¯ÄÚ¿Æ×¨Òµ£©¡£
v?BX 4FO Ò»¾Å¾Å°ËÄ격ʿÑо¿ÉúÈëѧ¿¼ÊÔÊÔÌâ
fBBNP
) £¨ÃâÒßѧרҵºÍרҵ»ù´¡£©
IOmQ1X7, Ò».Ãû´Ê½âÊÍ£¨Ã¿Ìâ3·Ö£¬¹²45·Ö£©
\)'s6>58| 1.Co-stimulators (or co-stimulating molecules)
y<jW7GNt 2.NK-kB
d?^bCf+< 3.Immunoglobulin superfamily
XoEiW R 4.antigen-presenting cell (APC)
<|9s {z 5.death domain
{^zieP! 6.CCR and CXCR
Wm\HZ9PN 7.Lectin (or mitogen)
^[6eo8Ck> 8.Clusters of differentiation, CD)
q66!xhp;? 9.B7 family
XA75tU[# 10.Cytotoxic T lymphocyte, CTL)
W,dqk=n 11.IL-15 and IL-15 receptor (IL-15R)
0V6gNEAUg 12.MHC restriction
~ /s(.oji 13.Affinity-chromatography
E-jL"H* 14.Cyctosprin A, CsA
e<o{3*%p) 15.Antibody-dependent cell-mediated cytotoxicity, ADCC)
|^p7:)cy ¶þ.ÎÊ´ðÌ⣨ÿÌâ10·Ö£¬¹²30·Ö£©
:4RD.l 1.ºÎΪTh1ºÍ Th2ÑÇȺ£¿ÈçºÎ¼ì²â£¿ÔÚÁÙ´²ÉÏÓкÎÒâÒ壿
2k}~"!e1 2.ÊÔÊöÃâÒßÇòµ°°×£¨Ig£©µÄ½á¹¹Ó빦ÄܵĹØÏµ¡£
# rnO=N8 3.ÊԱȽÏTϸ°ûÊÜÌ壨TCR/CD3£©ÓëBϸ°ûÊÜÌ壨BCR£©µÄ×é³É¡¢½á¹¹¼°Æäʶ±ð ¿¹ÔµÄÌØµã¡£
"cSH[/ Èý.Ñ¡ÔñÎÊ´ðÌ⣨¸÷רҵ¿¼ÉúÖ»´ðÒ»µÀ±¾×¨ÒµÊÔÌ⣬25·Ö£©
nv>|,&; ÃâÒßѧרҵ£º
_"Yi>.{] 1.ÊÔÊöB7/CD28, CTLA-4£¬CD40/CD40L£¬LFA-1/ICAM-1£¬CD2/LFA-3µÄ½á¹¹¡¢·Ö²¼ÒÔ¼°Ï໥×÷Óúó½éµ¼µÄÖ÷ÒªÉúÎïѧ¹¦ÄÜ¡£
d$.t0-lC Ïû»¯ÄÚ¿Æ£º
sk*AlSlM 2.Ö×Áö¿¹Ô·ÖΪÄļ¸Àࣿ»úÌ忹Ö×ÁöÃâÒßÖ÷ÒªÓÐÄÄЩÒòËØ£¨»úÖÆ£©£¿¼òÊöÌá¸ß¿¹Ö×ÁöÃâÒßÑо¿µÄÂԲߡ£
/6)6 ѪҺ²¡Ñ§×¨Òµ£º
>
Q[L,I 3.ºÎΪ°×Ѫ²¡µÄÃâÒßѧ·ÖÐÍ£¿ºÎÎªÒÆÖ²ÎËÞÖ÷·´Ó¦£*****VHR£©£¿GVHR·¢ÉúµÄÖ÷ÒªÔÒò£¨Ìõ¼þ£©ÊÇʲô£¿
anLSD/'4W Ò»¾Å¾ÅÄê¾Å²©Ê¿ÉúÈëѧ¿¼ÊÔÊÔÌâ
XIQfgrGZ (רҵ»ù´¡: ÃâÒßѧ)
L[v-5u) Ò».Ãû´Ê½âÊÍ(ÿÌâ5·Ö,¹²45·Ö)
w}2 ;f= 1. ADCC(antibody dependent cell-mediated cytotoxicity)
8K(3{\J[V 2. »·æß¾úËØ(cyclosporin)
MP"Pqt 3. KIR(killer cell inhibitory receptor)
2^Y@e=^A 4. HLDA(human leucocyte differentiation antigen)
2e~ud9, 5. Interleukin 18(IL-18)
-jN:~. 6. ÕûºÏËØ(integrin)
7-Bttv{ 7. Fas/FasL
;&="aD 8. FcR(ÃâÒßÇòµ°°×Fc¶ÎÊÜÌå)
"h.-qQGU% 9. ϸ°û¼äÕ³¸½·Ö×Ó(ICAM)
d3%1P)
10. Th1/Th2
W>jgsR79M 11. »ùÒòÒßÃç(DNAÒßÃç)
"^
?|=sQ 12. chemokines and chemokine receptor
{|cuu"j26 13. ÃâÒßÄÍÊÜ
H_3-"m &3 14. ¹²´Ì¼¤·Ö×Ó
*hugQh]a 15. ËÀÍö½á¹¹Óò(death domain)
KBVW<;C$ ¶þ.ÎÊ´ðÌâ(µÚ1¡¢2Ìâ¸÷18·Ö,µÚ3Ìâ19·Ö)
-TL `nGF 1. ÊԱȽÏɱÉËÐÔTϸ°û(CTL)Óë×ÔȻɱÉËϸ°û(NK)ÔÚɱÉ˰Ðϸ°û¹ý³ÌÖÐ,ʶ±ðϸ°û¶¾¼°½éµ¼ÃâÒß¹¦ÄÜÓкβ»Í¬?
#p<1@, 2. 70Äê´úÒÔÀ´,ÓйØIgºÍÌåÒºÃâÒßÑо¿´æÔÚÒÔϼ¸ÏîÖØ´ó·¢ÏÖºÍÍ»ÆÆ¶ø»ñµÃҽѧºÍÉúÎïѧŵ±´¶û½±,Çë·Ö±ð²ûÊöËüÃǵÄÀíÂÛÒâÒå¼°ÔÚҽѧʵ¼ùÖеÄÓ¦Óá£
'dT JE--@ £¨1£©1972Ä꣺θµ°°×øºÍľ¹Ïµ°°×øˮ½âIg£¬»ñµÃFab¡¢Fc¡¢F£¨ab¡¯£©2µÈƬ¶Î
2VSs#z! £¨2£©1977Ä꣺·ÅÉäÃâÒß·¨
R.ZC|bPiD £¨3£©1984Ä꣺ÁܰÍϸ°ûÔÓ½»ÁöºÍµ¥¿Ë¡¿¹Ìå
#~ikR.-+Eq £¨4£©1987Äê: Ig»ùÒòµÄ½á¹¹
J2tD).G 3. ½üÄêÀ´ÔÚÖ×ÁöÃâÒßÑо¿ÁìÓòÖÐÓÐÄÄÐ©ÖØÒª½øÕ¹?ÊÔÊöµ±Ç°Ìá¸ß»úÌ忹Ö×ÁöÃâÒßµÄÖ÷Òª²ßÂÔ¡£
z>n<+tso Ò»¾Å¾Å¾ÅÄ격ʿÉúÈëѧ¿¼ÊÔÊÔÌâ(ÃâÒßѧרҵ)
M{sn{ ÎÊ´ðÌâ(ÿÌâ25·Ö)
' pnkm0=` 1. ÊԱȽÏTϸ°ûÊÜÌ壨TCR£©¡¢Bϸ°ûÊÜÌ壨BCR£©ºÍNKϸ°ûÊÜÌ壨NKCR£©µÄ×é³É£¬Ê¶±ðÅäÌåÒÔ¼°ÐźÅתµ¼µÄÒìͬµã¡£
Ndb_| 2. ÒÔÐØÏÙÒÀÀµ¿¹Ô´Ì¼¤»úÌå²úÉú¿¹ÌåµÄÃâÒßÓ¦´ðΪÀý£¬Tϸ°ûºÍBϸ°ûÊÇÈçºÎÏ໥×÷Óã¿ÓÐÄÄЩճ¸½·Ö×Ӻ͹²´Ì¼¤·Ö×Ó²ÎÓëT¡¢Bϸ°ûµÄÏ໥×÷Óã¿
*^h$%<QI 3. Éö×ÛºÏÕ÷³öѪÈÈ(HFRS)²¡¶¾µÄ½á¹¹»ùÒòÒѾ¸ãÇå³þ,ΪÁË֤ʵHFRS²¡¶¾¸ÐȾ»úÌå(ÒÔBalb/CСÊóΪÀý)¿É²úÉúHFRS²¡¶¾ºËÒ¿ǵ°°×(NP)ÌØÒìÐÔCTL,²¢ÔÚÃâÒß·À»¤ÖÐÆðÖØÒª×÷ÓÃ,ÇëÓ¦ÓÃÃâÒßѧÀíÂۺͷ½·¨,Éè¼ÆÒ»ÏµÍ³ÊµÑé,¼ÓÒÔ֤ʵ¡£
`EFPY$9`D 4. Àý¾Ù¶þ¸ö½üÄêÀ´Ï¸°ûºÍ·Ö×ÓÃâÒßѧÑо¿ÖгöÏÖµÄеÄÈȵã,Çë·Ö±ðÆÀÊöÆäÑо¿ÒâÒå¡¢·¢Õ¹Ç÷ÊÆÒÔ¼°Ó¦ÓÃǰ¾°¡£